A Agência Nacional de Saúde dos Estados Unidos abriram um fundo com a finalidade de desenvolvimento de um pâncreas artificial.
Para saber mais e como doar, leia abaixo e entre no site.
I am writing about a funding opportunity for artificial pancreas research. NIH has recently announced an RFA entitled, “Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D). Towards an Artificial Pancreas [(SBIR) (R43/R44)]”
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-10-008.html
The Letter of Intent receipt date is November 1, 2010. Here is an opportunity to apply for funding to develop a diabetes technology product which is much needed.
David Klonoff, M.D. David C. Klonoff, M.D., F.A.C.P. Clinical Professor of Medicine, U.C. San FranciscoEditor-in-Chief, Journal of Diabetes Science and Technology (in PubMed)Medical Director, Diabetes Research Institute Mills-Peninsula Health Services 100 South San Mateo Drive, Room 5147 San Mateo, California 94401 USA.
Até mais.
Para saber mais e como doar, leia abaixo e entre no site.
I am writing about a funding opportunity for artificial pancreas research. NIH has recently announced an RFA entitled, “Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D). Towards an Artificial Pancreas [(SBIR) (R43/R44)]”
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-10-008.html
The Letter of Intent receipt date is November 1, 2010. Here is an opportunity to apply for funding to develop a diabetes technology product which is much needed.
David Klonoff, M.D. David C. Klonoff, M.D., F.A.C.P. Clinical Professor of Medicine, U.C. San FranciscoEditor-in-Chief, Journal of Diabetes Science and Technology (in PubMed)Medical Director, Diabetes Research Institute Mills-Peninsula Health Services 100 South San Mateo Drive, Room 5147 San Mateo, California 94401 USA.
Até mais.
Comentários
Postar um comentário